AbbVie
ABBV
#31
Rank
$297.70 B
Marketcap
$168.59
Share price
1.22%
Change (1 day)
21.60%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - P/B ratio

P/B ratio as of June 2024 : 37.0

According to AbbVie's latest financial reports the company has a price-to-book ratio of 37.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AbbVie - P/B ratio (from 2012 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3126.359.17%
2022-12-3116.56.61%
2021-12-3115.57.36%
2020-12-3114.4-190.14%
2019-12-31-16.0-0.73%
2018-12-31-16.1-153.29%
2017-12-3130.337.99%
2016-12-3122.0-9.2%
2015-12-3124.2-59.56%
2014-12-3159.8220.35%
2013-12-3118.716.28%
2012-12-3116.0
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
1.69-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
64.7 74.97%๐Ÿ‡บ๐Ÿ‡ธ USA
31.9-13.78%๐Ÿ‡บ๐Ÿ‡ธ USA
2.22-94.01%๐Ÿ‡บ๐Ÿ‡ธ USA
4.64-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
5.05-86.36%๐Ÿ‡บ๐Ÿ‡ธ USA
6.58-82.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.96-86.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.71-84.56%๐Ÿ‡บ๐Ÿ‡ธ USA